Pharmstandard Co Stock Joint Public Net Worth & Insider Trades

Pharmstandard Co Stock Joint Public Argos Therapeutics Inc

As of June 23, 2017

What is Pharmstandard Co Stock Joint Public's Net Worth?

The current estimated net worth of Argos Therapeutics Inc's Pharmstandard Co Stock Joint Public is estimated to be about $10.47B . Pharmstandard Co Stock Joint Public owns about 0 unit of Argos Therapeutics Inc common stock. In the last 3 years at Argos Therapeutics Inc, Pharmstandard Co Stock Joint Public has sold an estimated value of $0 worth.

What is Pharmstandard Co Stock Joint Public's Past Insider Trading?

Pharmstandard Co Stock Joint Public's largest purchase order was 5,983,549 units , worth over $10.2M on February 12, 2014. In total, Pharmstandard Co Stock Joint Public has made about 14 transactions over 3 years of their time at Argos Therapeutics Inc. Pharmstandard Co Stock Joint Public usually trades in August and September, with the busiest year in 2016. The most recent transaction was a purchase order of 0 unit , worth over $0 on June 23, 2017.

SA International Pharmstandard, Pharmstandard Co Stock Joint

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Pharmstandard Co Stock Joint Public's' Mailing Address?

  • Mailing address is Likhachevsky Drive 5 "B" Dolgoprudny 1Z 141701 Russian Federation

Argos Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Jeffrey D. Abbey 2016 $450,000 $356,500 $1,029,892 $26,477 $1,862,869
Jeffrey D. Abbey 2015 $450,000 $202,500 $714,502 $14,861 $1,381,863
Charles A Nicolette, Ph.D. 2016 $325,000 $121,875 $720,925 $18,669 $1,186,469
Charles A Nicolette, Ph.D. 2015 $325,000 $108,875 $446,564 $17,217 $897,656
Lee F. Allen, M.D., Ph.D. 2016 $407,292 $389,375 $1,016,592 $70,120 $1,883,379
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1105533/000117184317003980/def14a_070617.htm

What are Argos Therapeutics Inc's Past Insider Trades?

Argos Therapeutics Inc's most recent insider trade came on January 12, 2018 by Lori R Harrelson who sold 64,329 units worth $10.59K . In the last 4 years, insiders at Argos Therapeutics Inc have sold an estimated value of $79.34M and bought an estimated value of $13.75M worth of shares. Insider trading is most common in January, with the busiest year in 2016. The most active traders at the company are Jeffrey Abbey, Chief Executive Officer,  Pharmstandard Co Stock Joint,  and Sa International Pharmstandard .

ARGOS THERAPEUTICS INC Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1